Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Jun Ishizaki"'
Autor:
Daisuke Hiraoka, Jun Ishizaki, Jun Yamanouchi, Takatsugu Honda, Toshiyuki Niiya, Erika Horimoto, Kenta Horie, Hitoshi Yamasaki, Takuya Matsumoto, Koichiro Suemori, Hitoshi Hasegawa, Katsuto Takenaka
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss 2 (2024)
Objectives Hydroxychloroquine (HCQ) has been shown to reduce thrombotic events in patients with SLE. However, the antiplatelet effects of HCQ are only supported by the platelet aggregation assay, which is a non-physiological test. The total thrombus-
Externí odkaz:
https://doaj.org/article/9b2b82fe11bb48f18f153048a308cfff
Autor:
Jun Ishizaki, Ayako Takemori, Kenta Horie, Daisuke Hiraoka, Koichiro Suemori, Takuya Matsumoto, Ken-ei Sada, Koichi Amano, Masayoshi Harigai, Yoshihiro Arimura, Hirofumi Makino, Katsuto Takenaka, Nobuaki Takemori, Hitoshi Hasegawa, for the Research Committee of Intractable Vasculitis Syndrome and the Research Committee of Intractable Renal Disease of the Ministry of Health, Labour and Welfare of Japan
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-15 (2021)
Abstract Background We previously identified tissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker of disease activity that distinguished mildly or highly active antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) from re
Externí odkaz:
https://doaj.org/article/a72fdcfdd8d64c048ec2f65e4f092f5d
Autor:
Jun Ishizaki, Ayako Takemori, Koichiro Suemori, Takuya Matsumoto, Yoko Akita, Ken-ei Sada, Yukio Yuzawa, Koichi Amano, Yoshinari Takasaki, Masayoshi Harigai, Yoshihiro Arimura, Hirofumi Makino, Masaki Yasukawa, Nobuaki Takemori, Hitoshi Hasegawa, for the Research Committee of Intractable Vasculitis Syndrome and the Research Committee of Intractable Renal Disease of the Ministry of Health, Labour and Welfare of Japan
Publikováno v:
Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-17 (2017)
Abstract Background Targeted proteomics, which involves quantitative analysis of targeted proteins using selected reaction monitoring (SRM) mass spectrometry, has emerged as a new methodology for discovery of clinical biomarkers. In this study, we us
Externí odkaz:
https://doaj.org/article/89052af2001949909cd29aa19a4d85f9
Autor:
Sachiko Onishi, Endy Adnan, Jun Ishizaki, Tatsuhiko Miyazaki, Yuki Tanaka, Takuya Matsumoto, Koichiro Suemori, Masachika Shudou, Takafumi Okura, Hiroyuki Takeda, Tatsuya Sawasaki, Masaki Yasukawa, Hitoshi Hasegawa
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0126564 (2015)
Systemic lupus erythematosus (SLE) is characterized by production of a variety of autoantibodies. Although anti-double-stranded DNA (anti-dsDNA) antibodies contribute to the pathogenesis of lupus nephritis (LN), they are not sufficient for diagnosis
Externí odkaz:
https://doaj.org/article/d84520eae11449ff86c3b1f76a6fa6ef
Autor:
Takahiko Sugihara, Hajime Yoshifuji, Haruhito A Uchida, Yasuhiro Maejima, Yoshiko Watanabe, Kazuo Tanemoto, Natsuka Umezawa, Yusuke Manabe, Jun Ishizaki, Tsuyoshi Shirai, Hiroko Nagafuchi, Hitoshi Hasegawa, Hiroaki Niiro, Tomonori Ishii, Yoshikazu Nakaoka, Masayoshi Harigai
Publikováno v:
Modern Rheumatology.
Objective To develop a proposal for giant cell arteritis (GCA) remission criteria in order to implement a treat-to-target algorithm. Methods A task force consisting of 10 rheumatologists, three cardiologists, one nephrologist, and one cardiac surgeon
Autor:
Takahiko Sugihara, Haruhito A. Uchida, Hajime Yoshifuji, Yasuhiro Maejima, Taio Naniwa, Yasuhiro Katsumata, Takahiro Okazaki, Jun Ishizaki, Yohko Murakawa, Noriyoshi Ogawa, Hiroaki Dobashi, Tetsuya Horita, Yoshiya Tanaka, Shunsuke Furuta, Tsutomu Takeuchi, Yoshinori Komagata, Yoshikazu Nakaoka, Masayoshi Harigaii
Publikováno v:
Modern Rheumatology; Nov2023, Vol. 33 Issue 6, p1145-1153, 9p
Autor:
Daisuke Hiraoka, Jun Ishizaki, Kenta Horie, Takuya Matsumoto, Koichiro Suemori, Katsuto Takenaka, Hitoshi Hasegawa
Publikováno v:
Modern Rheumatology Case Reports. 6:194-198
Clinically amyopathic dermatomyositis (CADM) patients often develop rapidly progressive interstitial lung disease (RP-ILD). A high level of anti-melanoma differentiation-associated gene 5 antibodies (anti-MDA5 Ab) before treatment is associated with
Publikováno v:
Joho Chishiki Gakkaishi. 31:493-496
Publikováno v:
Joho Chishiki Gakkaishi. 31:395-410
Autor:
Takahiko Sugihara, Haruhito A Uchida, Hajime Yoshifuji, Yasuhiro Maejima, Taio Naniwa, Yasuhiro Katsumata, Takahiro Okazaki, Jun Ishizaki, Yohko Murakawa, Noriyoshi Ogawa, Hiroaki Dobashi, Tetsuya Horita, Yoshiya Tanaka, Shunsuke Furuta, Tsutomu Takeuchi, Yoshinori Komagata, Yoshikazu Nakaoka, Masayoshi Harigai
Publikováno v:
Modern Rheumatology.
Objective: We aimed to identify associations between patterns of large-vessel lesions of large-vessel giant cell arteritis (LV-GCA) and treatment outcomes.Methods: We extracted data on 68 newly-diagnosed patients with LV-GCA from a retrospective, mul